Brief: Pivot Pharma Enters U.S. CBD Market With Its Proprietary CBD Product Line
08/10/2019 19:31
Oct 8 (Reuters) - Pivot Pharmaceuticals Inc PVOT.CD :
* PIVOT PHARMA ENTERS U.S. CBD MARKET WITH ITS PROPRIETARY
CBD
PRODUCT LINE
* CONTRACT WITH F&B COSMETICS TO MANUFACTURE CO’S
DIFFERENTIATED
PORTFOLIO OF CBD BASED WELLNESS PRODUCTS IN THE U.S.
Source text for Eikon: (https://bit.ly/2AQtxoG)
Further company coverage: PVOT.CD
((Reuters.Briefs@thomsonreuters.com;))
Recent news on BetterLife Pharma
See all newsBrief: Betterlife Pharma Provides Scientific Update On Neuroplastogenic Activity Of BETR-001
Brief: Betterlife Pharma Advanced In IND-enabling Studies For BETR-001
Brief: BetterLife Announces Closing Of $1.168 Million Convertible Debentures To Further Advance IND-Enabling Studies Of Its Non-Hallucinogenic LSD-Based Drug Candidate BETR-001
Brief: Omineca Announces $2 Mln Brokered Financing Of Flow-Through Units
Brief: Betterlife Announces Pricing Of Proposed Offering Of Units